Women Health Therapeutics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Growing awareness regarding cancer, menopause, osteoporosis, and infections is expected to drive the market growth for women’s health therapeutics.
Global Women Health Therapeutics Market is valued at USD 112.42 Billion in 2018 and expected to reach USD 208.16 Billion by 2025 with the CAGR of 9.2 % over the forecast period.
Scope of Global Women Health Therapeutics Market Reports –
In the healthcare industry, women health therapeutics market is a booming segment as every woman has to deal with some kind of gynecological disorder at some point of their lifetime. While most of the gynecological diseases can be cured with proper treatment but in certain cases they can prove fatal unless diagnosed at the right time. In present times, women health therapeutics market has notable pipeline of promising molecules at several stages of clinical development. Some of such molecules are AZD4901, romosozumab (AMG785), abaloparatide, elagolix, and vaginorm.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=67382&RequestType=Sample
Global women health therapeutics market report is segmented on the basis of type, end-user and regional & country level analysis. Based on type, global women health therapeutics market is classified as infection, pregnancy, and oncology. Again oncology is further sub segmented into cervical cancer, ovarian cancer, uterine cancer, vaginal and vulvar cancer.
The regions covered in this women health therapeutics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of women health therapeutics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Women Health Therapeutics Market Report-
Global women health therapeutics market report covers prominent players like Abbott Laboratories, Amgen, Inc., Astellas Pharma Inc., Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Merck& Co., Inc., Novartis International AG, Novogyne Pharmaceuticals, Novo Nordisk A/S, Pfizer, Inc., Oasmia Pharmaceutical Company, Radius Health Company, Repros Therapeutics Inc., Sanofi S.A., Takeda Pharmaceutical Company Ltd., Teva Pharmaceutical Industries Ltd., Tsumura & Co., Warner Chilcott Corp., Zosano Pharma Inc. and others.
Teva Announced the Launch of Generic Vagifem in the United States
July 24th, 2017; Teva Pharmaceutical Industries Ltd, announced the launch of a generic version of Vagifem (estradiol vaginal inserts), 10 mcg in the U.S. Estradiol vaginal inserts are an estrogen indicated for the treatment of atrophic vaginitis due to menopause. Estradiol vaginal inserts had annual sales of approximately USD 379 million in the U.S. according to IMS data as of May 2017.Estradiol vaginal inserts add to Teva’s existing portfolio of more than 70 women’s health products. With nearly 600 generic medicines available, Teva has the largest portfolio of FDA-approved generic products on the market and holds the leading position in first-to-file opportunities, with over 100 pending first-to-files in the U.S. Currently, one in six generic prescriptions dispensed in the U.S. is filled with a Teva generic product.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=67382&RequestType=Methodology
Global Women Health Therapeutics Market Dynamics–
Rise in cases of infertility and increasing incidences of chronic disorders among women are seen as the key forces driving the growth of the global women health therapeutics market. According to WHO, infertility in women is ranked as the 5th highest serious disability worldwide owing to which rise in need for infertility therapeutics can be seen in present times. Numerous facts and stats support the high infertility rate at global level. According to CDC, around 11.9% of women have ever received any kind of infertility services in their lifetime. However, patent expiry of blockbuster drugs is expected to pose challenge in the growth of the global women health therapeutics market. In spite of that, supportive government initiatives coupled with improving healthcare infrastructure in developing economies are projected to create significant growth opportunities for the global market.
North America is Expected to Dominate the Global Women Health Therapeutics Market
North America holds the largest market share in the global market due to the growing focus towards women health and increasing elderly population. High prevalence of chronic disorders such as breast cancer in the U.S. has further boosted the growth of the women health therapeutics market in this region. According to U.S. breast cancer statistics, in 2019, an estimated 268,600 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 62,930 new cases of non-invasive breast cancer. Asia Pacific is projected to witness the highest growth rate during the forecast period owing to the growing awareness about the diversified treatment options for women health issues coupled with rising prevalence of urological disorders within the regional countries.
Key Benefits for Global Women Health Therapeutics Market Report–
- Global Women Health Therapeutics Market report covers in depth historical and forecast analysis.
- Global Women Health Therapeutics Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Women Health Therapeutics Market report helps to identify opportunities in market place.
- Global Women Health Therapeutics Market report covers extensive analysis of emerging trends and competitive landscape.
Get Full information of This Report @ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Women-Health-Therapeutics-Market-Share/Summary
Global Women Health Therapeutics Market Segmentation: –
- Cervical Cancer
- Ovarian Cancer
- Uterine Cancer
- Vaginal & Vulvar Cancer
By Regional & Country Analysis:
- North America
- Asia Pacific
- Southeast Asia
- Latin America
- The Middle East and Africa
- Rest of Middle East and Africa
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org